UBS Starts Owens & Minor (OMI) at Sell
- Amazon, health stocks weigh on S&P, Nasdaq; Chevron lifts Dow
- ExxonMobil (XOM) Tops Q3 EPS by 5c; CapEx Light of Views
- Baker Hughes (BHI), General Electric (GE) in Partnership Talks, Not Merger Talks
- AbbVie (ABBV) Tops Q3 EPS by 1c; Boosts FY16 EPS Outlook
- Amazon.com (AMZN) Misses Q3 EPS by 26c, Offers Q4 Guidance
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
UBS initiates coverage on Owens & Minor (NYSE: OMI) with a Sell rating and a price target of $31.50.
Analyst Michael Cherny commented, "We are initiating coverage on Owens & Minor with a Sell rating and a $31.50 price target. We recognize the early steps being taken by management to position the company for the shift towards solving healthcare’s complexities and expanding its services offerings. However, the implementation of these items will take time to come to fruition, and in the meantime the headwinds created by the Kaiser contract, combined with general slow utilization, will hamper EPS growth."
Shares of Owens & Minor closed at $33.68 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Leerink Partners Downgrades McKesson (MCK) to Market Perform
- Chardan Capital Markets Starts Astrotech Corporation (ASTC) at Buy
- Stifel Upgrades Hub Group (HUBG) to Buy
Create E-mail Alert Related CategoriesAnalyst Comments, Hot New Coverage, New Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!